MECP2 duplication syndrome: Recent advances in pathophysiology and therapeutic perspectives
Brain and Development · 2025
DOI: 10.1016/j.braindev.2025.104371 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Brain and Development, 2025. Verfasst von Yuichi Akaba und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Asahikawa Medical University, Asahikawa, Hokkaido, Japan. Hauptthemen laut MEDLINE: Methyl-CpG-Binding Protein 2, X-Linked Intellectual Disability. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 90 Literaturangaben. Gefördert von: Ministry of Health, Labour and Welfare.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Asahikawa Medical University, Asahikawa, Hokkaido, Japan.
- Department of Pediatrics, Asahikawa Medical University, Asahikawa, Hokkaido, Japan. Electronic address: satoru5p@asahikawa-med.ac.jp.
Förderung
- Ministry of Health, Labour and Welfare
Zitieren
APA
Akaba, Y., & Takahashi, S. (2025). MECP2 duplication syndrome: Recent advances in pathophysiology and therapeutic perspectives. Brain and Development. https://doi.org/10.1016/j.braindev.2025.104371
Vancouver
Akaba Y, Takahashi S. MECP2 duplication syndrome: Recent advances in pathophysiology and therapeutic perspectives. Brain and Development. 2025. doi:10.1016/j.braindev.2025.104371
BibTeX
@article{Akaba2025,
author = {Akaba, Yuichi and Takahashi, Satoru},
title = {MECP2 duplication syndrome: Recent advances in pathophysiology and therapeutic perspectives},
journal = {Brain and Development},
year = {2025},
doi = {10.1016/j.braindev.2025.104371}
}
EUVIMED